Pharmacological Treatment A number of studies have pointed out that Postpartum Depression (PPD) is essentially the same as Major Depression (MDD) and, therefore, benefits from pharmacological treatment with antidepressant medication, but very few studies have conducted randomized controlled trails comparing different medication and placebos.1 In general, pharmacological treatment of MDD has proven to be...
A previous article already introduced some of the symptoms and risks of Postpartum Depression (PPD), but I would still like to emphasize the profound effects of this disorder. In this particular stage of life, depression does not only hurt the new mother, but poses threat for the well-being of the baby as well. In...
Postpartum Depression (PPD): A Psychological Disorder Postpartum Depression (PPD) is a fairly common complication of childbirth and often accompanies the postpartum period, leading to psychological suffering for the mother, negative effects on the infant and strained family relationships.1 Pregnancy, childbirth and the postpartum period involve intense emotional experiences for most women and are characterized...
Reactive Attachment Disorder: Etiology, Symptoms, Affected Brain Areas and Treatment Reactive Attachment Disorder (RAD) is characterized by considerably disturbed and inappropriate social interaction, across situations, that is manifested before the age of five (DSM-IV-R). Evidence for the disorder is usually seen in continuous failure to respond appropriately in social situations (being hypervigilant, inhibited, or...
Prozak (fluoxetine) is among the Selective Serotonin Reuptake Inhibitors (SSRIs), aka. second-generation antidepressants. As all SSRIs, Prozak blocks the reuptake transporter for serotonin, preventing it from being taken back to the axon terminal. Since this transporter is blocked, serotonin remains in the synaptic cleft for long periods, continuing to have its effect on the...
